Cabaletta Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cabaletta Bio and other ETFs, options, and stocks.About CABA
Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies.
CEOSteven Nichtberger
CEOSteven Nichtberger
Employees161
Employees161
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2017
Founded2017
Employees161
Employees161
CABA Key Statistics
Market cap245.96M
Market cap245.96M
Price-Earnings ratio-1.01
Price-Earnings ratio-1.01
Dividend yield—
Dividend yield—
Average volume2.57M
Average volume2.57M
High today$2.70
High today$2.70
Low today$2.50
Low today$2.50
Open price$2.57
Open price$2.57
Volume2.23M
Volume2.23M
52 Week high$3.67
52 Week high$3.67
52 Week low$0.9857
52 Week low$0.9857
Stock Snapshot
As of today, Cabaletta Bio(CABA) shares are valued at $2.60. The company's market cap stands at 245.96M, with a P/E ratio of -1.01.
During the trading session on 2025-12-07, Cabaletta Bio(CABA) shares reached a daily high of $2.70 and a low of $2.50. At a current price of $2.60, the stock is +4.0% higher than the low and still -3.7% under the high.
Trading activity shows a volume of 2.23M, compared to an average daily volume of 2.57M.
The stock's 52-week range extends from a low of $0.99 to a high of $3.67.
The stock's 52-week range extends from a low of $0.99 to a high of $3.67.
Analyst ratings
78%
of 9 ratingsBuy
77.8%
Hold
22.2%
Sell
0%
People also own
Based on the portfolios of people who own CABA. This list is generated using Robinhood data, and it’s not a recommendation.